Search for: "In re: Avandia Marketing Sales Practices & Products Liability Litigation"
Results 21 - 40
of 41
Sorted by Relevance
|
Sort by Date
26 Feb 2016, 10:48 am
In In re Avandia Marketing & Sales Practices and Product Liability Litigation, No. 15-2145, 2016 WL 559216 (3d Cir. [read post]
9 Aug 2011, 4:00 am
Which brings me to one of the lessons this episode has for lawyers trying to build a personal injury or product liability law practice. [read post]
3 Nov 2014, 5:12 am
Conn. 2012); In re Meridia Products Liability Litigation, 328 F. [read post]
25 Feb 2012, 10:04 am
Supp. 2d 420 (E.D.N.Y. 2011) Avandia In re Avandia Marketing, Sales Practices and Product Liability Litigation, 2011 WL 13576, *12 (E.D. [read post]
3 Mar 2009, 5:00 am
Litigants keep raising, and courts keep addressing, this issue, too.Most recently, in In Re: Avandia Marketing, Sales Practices And Products Liability Litigation, 2009 U.S. [read post]
24 Dec 2015, 8:20 am
The legislature chose not to punish FDA-regulated activity, but the court nullified that legislative decision, with practically no discussion.In re Avandia Marketing, Sales Practices & Product Liability Litigation, 804 F.3d 633 (3d Cir. 2015). [read post]
7 Jan 2014, 9:22 am
See, e.g., In re Agent Orange Product Liab. [read post]
6 Jul 2009, 5:30 am
., Mar 12, 2009)(NO. 2:05-CV-293MEF) In re Avandia Marketing, Sales Practices and Products Liability Litigation, Slip Copy, 2009 WL 498936 (E.D.Pa., Feb 25, 2009)(NO. [read post]
2 Jul 2012, 11:57 am
In In re Avandia Marketing, Sales Practices and Products Liability Litigation, the court held that the Medicare Secondary Payer Act (“MSP”) provides Medicare Advantage Organizations (“MAOs”) with a private cause action to seek recovery against a primary payer (such as a liability insurer or self-insured defendant in a personal injury matter) in Federal court. [read post]
2 Jul 2012, 11:57 am
In In re Avandia Marketing, Sales Practices and Products Liability Litigation, the court held that the Medicare Secondary Payer Act (“MSP”) provides Medicare Advantage Organizations (“MAOs”) with a private cause action to seek recovery against a primary payer (such as a liability insurer or self-insured defendant in a personal injury matter) in Federal court. [read post]
2 Jan 2014, 8:08 am
See, e.g., In re Agent Orange Product Liab. [read post]
31 Dec 2015, 5:12 am
Full disclosure: Reed Smith is involved in Caplinger, so consider this entry a non-RS post.In re Celexa & Lexapro Marketing & Sales Practices Litigation, 779 F.3d 34 (1st Cir. 2015). [read post]
9 Apr 2016, 8:58 am
In re Zoloft Prod. [read post]
17 Jan 2017, 3:00 am
The District Court, however, noted that because the plaintiffs’ claims have suffered similar injuries arising out of the defendants’ manufacture, marketing, or sale of propoxyphene products as In re Avandia Mktg., Sales Practices & Prods. [read post]
21 Jan 2023, 6:07 pm
I can help point you in the right direction for reputable marketing agencies if you need lead sources or looking to purchase retainers. [read post]
22 Aug 2014, 9:22 am
In In re Avandia Marketing, Sales Practices & Products Liability Litigation, 817 F. [read post]
5 Sep 2013, 12:24 pm
June 1, 2012); In re Avandia Marketing, Sales Practices & Products Liability Litigation, 817 F. [read post]
1 Oct 2009, 2:14 am
While we're on the subject, can we get judges to rewrite the New Jersey and Minnesota statutes of limitations to add a borrowing statute? [read post]
18 Nov 2010, 12:37 pm
In fact, it isn’t even the first drug/medical device product liability decision to do so. [read post]
3 Mar 2016, 5:19 am
Hall, “Regulating Direct-to-Consumer Advertising with Tort Law: Is the Law Finally Catching Up with the Market? [read post]
